Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Meiji Seika Pharma Co., Ltd

http://www.meiji-seika-pharma.co.jp/english/

Latest From Meiji Seika Pharma Co., Ltd

Texas To Tokyo: Japan Darvias Approval Marks End Of Long Development Road

Solasia's arsenical drug darinaparsin has received its global-first approval in Japan, for PTCL, in a landmark for the Texan chemist who discovered it back in the 70s and paving the way for wider indications and Asian markets.

Japan Approvals

Keeping Track: Mycovia Vivjoa, BMS Camzyos Approvals Bring FDA’s 2022 Novel Drug Tally To 12

US FDA closed out the month of April with two new molecular entity approvals that address underserved markets but carry some safety concerns.

US FDA Performance Tracker Drug Review

A Year's Struggle: How Japan Is Recovering Damaged Generic Supplies After Quality Violations

Japan struggles to recover its ever-expanding supply chain for generic drugs after several key players had their production stopped because of a series of GMP violations. As the share of generics grows under government policy, some in the industry argue the problems are deeply rooted in a decades-old pricing system.

Japan Generic Drugs

Intas And Axantia Ink Middle East Ranibizumab Distribution Deal

Intas has secured a distributor for its ranibizumab biosimilar throughout select countries in the Middle East, while Phase III trials continue ahead of anticipated US approval.

Deals Biosimilars
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
    • Specialty Pharmaceuticals
  • Other Names / Subsidiaries
    • Chemo-Sero Therapeutic Research Institute of Japan
    • Meiji Holdings
    • Meiji Seika Kaisha
    • KM Biologics Co., Ltd.
    • Kaketsuken
    • Romeck Pharma, LLC
    • Meiji Pharma USA Inc.
UsernamePublicRestriction

Register